Association of MMP3-1171(5A > 6A) Polymorphism with Lung Cancer in Lebanon

被引：7
作者：
Fakhoury, Hana M. A. [1 ]
Noureddine, Sara [2 ]
Tamim, Hani [3 ]
Chmaisse, Hania [4 ]
Makki, Rajaa [2 ]
机构：
[1] King Saud bin Abdulaziz Univ Hlth Sci, Dept Basic Sci, Coll Med, Riyadh 11426, Saudi Arabia
[2] Beirut Arab Univ, Dept Biol & Environm Sci, Fac Sci, Beirut, Lebanon
[3] King Saud bin Abdulaziz Univ Hlth Sci, Dept Med Educ, Coll Med, Riyadh 11426, Saudi Arabia
[4] Beirut Arab Univ, Dept Pharmacol, Fac Pharm, Beirut, Lebanon
来源：
GENETIC TESTING AND MOLECULAR BIOMARKERS | 2012年 / 16卷 / 08期
关键词：
MATRIX-METALLOPROTEINASE (MMP)-1; SQUAMOUS-CELL CARCINOMA; COLORECTAL-CANCER; PROMOTER REGIONS; RISK; MATRIX-METALLOPROTEINASE-3; SUSCEPTIBILITY; PROGRESSION; BREAST; MMP1;
D O I：
10.1089/gtmb.2012.0042
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Matrix metalloproteinases (MMPs) are a family of enzymes that degrade extracellular matrix components and are involved in the development and progression of cancer. Lung cancer is the most commonly diagnosed cancer in Lebanon. This study was undertaken to investigate the association between -1171(5A > 6A) polymorphism in the promoter of MMP3 gene and the susceptibility to lung cancer in a Lebanese population. The MMP3 polymorphism was investigated in 41 lung cancer patients and 51 unrelated healthy controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. We found a significant association between MMP3-1171 5A allele and lung cancer (Odds ratio [OR] = 2.7, 95% [CI] = 1.3-5.3; Fisher's p-value = 0.005). This study may form an additional evidence for the association of MMP3 enzyme and genetic susceptibility to lung cancer.
引用
收藏
页码：988 / 990
页数：3
相关论文
共 21 条
[1]  
Biondi ML, 2000, CLIN CHEM, V46, P2023
[2]  
Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823
[3]   Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer [J].
Decock, J. ;
Paridaens, R. ;
Ye, S. .
CLINICAL GENETICS, 2008, 73 (03) :197-211
[4]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[5]   Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China [J].
Fang, SM ;
Jin, X ;
Wang, R ;
Li, Y ;
Guo, W ;
Wang, N ;
Wang, YM ;
Wen, DG ;
Wei, LZ ;
Zhang, JH .
CARCINOGENESIS, 2005, 26 (02) :481-486
[6]   Estimates of cancer incidence and mortality in Europe in 2008 [J].
Ferlay, J. ;
Parkin, D. M. ;
Steliarova-Foucher, E. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) :765-781
[7]   Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma [J].
Hashimoto, T ;
Uchida, K ;
Okayama, N ;
Imate, Y ;
Suehiro, Y ;
Hamanaka, Y ;
Ueyama, Y ;
Shinozaki, F ;
Yamashita, H ;
Hinoda, Y .
CANCER LETTERS, 2004, 211 (01) :19-24
[8]   Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma [J].
Hirata, H ;
Okayama, N ;
Naito, K ;
Inoue, R ;
Yoshihiro, S ;
Matsuyama, H ;
Suehiro, Y ;
Hamanaka, Y ;
Hinoda, Y .
CARCINOGENESIS, 2004, 25 (12) :2379-2384
[9]   Matrix metalloproteinase polymorphisms and bladder cancer risk [J].
Kader, A. Karim ;
Shao, Lina ;
Dinney, Colin P. ;
Schabath, Matthew B. ;
Wang, Yunfei ;
Liu, Jun ;
Gu, Jian ;
Grossman, H. Barton ;
Wu, Xifeng .
CANCER RESEARCH, 2006, 66 (24) :11644-11648
[10]   Matrix Metalloproteinases: Regulators of the Tumor Microenvironment [J].
Kessenbrock, Kai ;
Plaks, Vicki ;
Werb, Zena .
CELL, 2010, 141 (01) :52-67
123